541 related articles for article (PubMed ID: 9215638)
41. Intracellular signaling: Fleshing out the TGFbeta pathway.
Padgett RW
Curr Biol; 1999 Jun; 9(11):R408-11. PubMed ID: 10359694
[TBL] [Abstract][Full Text] [Related]
42. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.
Labbé E; Letamendia A; Attisano L
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8358-63. PubMed ID: 10890911
[TBL] [Abstract][Full Text] [Related]
43. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.
Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F
Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899
[TBL] [Abstract][Full Text] [Related]
44. Cloning and expression of a rat Smad1: regulation by TGFbeta and modulation by the Ras/MEK pathway.
Yue J; Hartsough MT; Frey RS; Frielle T; Mulder KM
J Cell Physiol; 1999 Mar; 178(3):387-96. PubMed ID: 9989785
[TBL] [Abstract][Full Text] [Related]
45. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
[TBL] [Abstract][Full Text] [Related]
46. Participation of an abnormality in the transforming growth factor-beta signaling pathway in resistance of malignant glioma cells to growth inhibition induced by that factor.
Zhang L; Sato E; Amagasaki K; Nakao A; Naganuma H
J Neurosurg; 2006 Jul; 105(1):119-28. PubMed ID: 16871886
[TBL] [Abstract][Full Text] [Related]
47. The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase.
Kretzschmar M; Liu F; Hata A; Doody J; Massagué J
Genes Dev; 1997 Apr; 11(8):984-95. PubMed ID: 9136927
[TBL] [Abstract][Full Text] [Related]
48. The Drosophila type II receptor, Wishful thinking, binds BMP and myoglianin to activate multiple TGFbeta family signaling pathways.
Lee-Hoeflich ST; Zhao X; Mehra A; Attisano L
FEBS Lett; 2005 Aug; 579(21):4615-21. PubMed ID: 16098524
[TBL] [Abstract][Full Text] [Related]
49. Requirement for the dynein light chain km23-1 in a Smad2-dependent transforming growth factor-beta signaling pathway.
Jin Q; Ding W; Mulder KM
J Biol Chem; 2007 Jun; 282(26):19122-32. PubMed ID: 17420258
[TBL] [Abstract][Full Text] [Related]
50. SMURF2 and SMAD7 induce SARA degradation via the proteasome.
Wojtowicz S; Lee S; Chan E; Ng E; Campbell CI; Di Guglielmo GM
Cell Signal; 2020 Aug; 72():109627. PubMed ID: 32283253
[TBL] [Abstract][Full Text] [Related]
51. MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma.
Eppert K; Scherer SW; Ozcelik H; Pirone R; Hoodless P; Kim H; Tsui LC; Bapat B; Gallinger S; Andrulis IL; Thomsen GH; Wrana JL; Attisano L
Cell; 1996 Aug; 86(4):543-52. PubMed ID: 8752209
[TBL] [Abstract][Full Text] [Related]
52. Differential expression, regulation, and induction of Smads, transforming growth factor-beta signal transduction pathway in leiomyoma, and myometrial smooth muscle cells and alteration by gonadotropin-releasing hormone analog.
Xu J; Luo X; Chegini N
J Clin Endocrinol Metab; 2003 Mar; 88(3):1350-61. PubMed ID: 12629129
[TBL] [Abstract][Full Text] [Related]
53. Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3-mediated signaling.
Goto D; Nakajima H; Mori Y; Kurasawa K; Kitamura N; Iwamoto I
Biochem Biophys Res Commun; 2001 Mar; 281(5):1100-5. PubMed ID: 11243848
[TBL] [Abstract][Full Text] [Related]
54. Expression of Smad4 and Smad7 in human thyroid follicular carcinoma cell lines.
Cerutti JM; Ebina KN; Matsuo SE; Martins L; Maciel RM; Kimura ET
J Endocrinol Invest; 2003 Jun; 26(6):516-21. PubMed ID: 12952364
[TBL] [Abstract][Full Text] [Related]
55. Aberrant TGFβ Signaling Contributes to Altered Trophoblast Differentiation in Preeclampsia.
Xu J; Sivasubramaniyam T; Yinon Y; Tagliaferro A; Ray J; Nevo O; Post M; Caniggia I
Endocrinology; 2016 Feb; 157(2):883-99. PubMed ID: 26653761
[TBL] [Abstract][Full Text] [Related]
56. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.
Itoh F; Asao H; Sugamura K; Heldin CH; ten Dijke P; Itoh S
EMBO J; 2001 Aug; 20(15):4132-42. PubMed ID: 11483516
[TBL] [Abstract][Full Text] [Related]
57. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
58. Smad7 misexpression during embryonic angiogenesis causes vascular dilation and malformations independently of vascular smooth muscle cell function.
Vargesson N; Laufer E
Dev Biol; 2001 Dec; 240(2):499-516. PubMed ID: 11784079
[TBL] [Abstract][Full Text] [Related]
59. Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFbeta signaling complexes in the cytoplasm and nucleus.
Xu L; Kang Y; Cöl S; Massagué J
Mol Cell; 2002 Aug; 10(2):271-82. PubMed ID: 12191473
[TBL] [Abstract][Full Text] [Related]
60. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice.
Goumans MJ; Mummery C
Int J Dev Biol; 2000 Apr; 44(3):253-65. PubMed ID: 10853822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
